data_2hm3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hm3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 122.811 1.291 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.801 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.4 m -86.52 149.36 48.79 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 112.227 -2.26 . . . . 0.0 106.888 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.1 160.12 4.76 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 CA-C-O 122.631 1.013 . . . . 0.0 113.521 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 p -56.58 119.77 6.65 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.127 -2.306 . . . . 0.0 109.104 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.25 1.97 59.23 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 111.467 -2.606 . . . . 0.0 114.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.0 t -69.42 133.82 48.23 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.035 0.917 . . . . 0.0 112.071 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -60.9 125.8 25.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.574 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.65 -18.46 10.85 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.725 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.09 -21.77 62.18 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.034 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.2 -11.46 58.68 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.659 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.37 147.14 89.91 Favored Pre-proline 0 N--CA 1.428 -1.532 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.062 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.659 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 85.0 Cg_endo -92.91 10.89 55.29 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.188 1.103 . . . . 0.0 112.278 -0.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -68.31 -38.69 81.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 84.3 m 57.58 38.66 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.672 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 113.78 17.87 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 56.8 Cg_exo -41.4 -32.85 1.39 Allowed 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 122.229 1.953 . . . . 0.0 113.18 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.861 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.61 -39.36 93.81 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.868 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.42 -32.72 25.95 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.37 -53.99 35.33 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.871 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.71 -15.55 10.94 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.861 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.9 pt20 -159.95 118.47 2.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.254 1.527 . . . . 0.0 113.73 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 N--CA 1.443 -0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.577 178.168 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 122.773 1.273 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.781 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.23 149.23 49.29 Favored Pre-proline 0 N--CA 1.425 -1.697 0 CA-C-N 112.299 -2.228 . . . . 0.0 106.517 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.75 160.93 4.99 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 CA-C-O 122.778 1.074 . . . . 0.0 113.575 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 p -56.64 119.2 5.74 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.98 -2.373 . . . . 0.0 109.228 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.13 59.3 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 111.496 -2.593 . . . . 0.0 114.138 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 50.7 t -69.21 134.28 49.03 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.069 0.938 . . . . 0.0 111.868 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -60.84 125.09 22.41 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.39 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -53.9 -18.37 8.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.516 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -22.01 62.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 117.199 0.499 . . . . 0.0 111.332 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 19.5 m -82.22 -11.25 58.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.635 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.49 147.21 89.65 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.362 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.635 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 96.6 Cg_endo -92.64 11.09 55.54 Favored 'Cis proline' 0 C--N 1.352 0.716 0 CA-C-N 120.13 1.082 . . . . 0.0 112.145 -0.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 23.2 mt-10 -68.17 -38.7 82.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 92.8 m 57.67 38.31 27.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.876 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -68.6 114.76 24.26 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 60.2 Cg_exo -42.54 -31.95 2.12 Favored 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.19 1.927 . . . . 0.0 113.058 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.51 -39.87 94.12 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.905 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.9 t -83.55 -32.34 25.91 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.0 m -65.47 -53.31 44.52 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.0 -1.455 . . . . 0.0 113.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.42 -15.36 8.95 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.705 ' O ' ' O ' ' A' ' 23' ' ' GLY . 7.3 pt20 -160.84 119.21 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.638 1.719 . . . . 0.0 115.159 -174.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 CA--C 1.519 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.753 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 122.817 1.294 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.77 149.29 47.98 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 112.223 -2.262 . . . . 0.0 106.906 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.38 160.42 4.94 Favored 'Trans proline' 0 N--CA 1.431 -2.179 0 CA-C-O 122.725 1.052 . . . . 0.0 113.506 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -56.57 119.76 6.64 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.156 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.49 1.77 58.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 111.495 -2.593 . . . . 0.0 114.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.9 t -69.69 133.78 47.92 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.056 0.931 . . . . 0.0 112.201 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -60.82 126.48 27.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.621 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.97 -17.85 10.49 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.649 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.2 -22.48 62.01 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 15.1 m -81.97 -11.53 58.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.24 147.4 90.47 Favored Pre-proline 0 N--CA 1.432 -1.366 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.632 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.3 Cg_endo -92.38 11.03 56.26 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.115 1.077 . . . . 0.0 111.868 -0.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.95 -38.97 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 85.7 m 57.91 38.55 27.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.697 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -68.11 114.82 23.2 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 73.5 Cg_exo -43.04 -32.35 2.76 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.242 1.961 . . . . 0.0 113.151 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.914 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.77 -39.81 93.66 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.157 -1.02 . . . . 0.0 111.677 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 t -82.99 -32.73 26.82 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -65.29 -54.14 33.52 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.783 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.45 -16.04 10.69 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.914 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 pt20 -160.93 123.96 3.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.373 1.586 . . . . 0.0 114.727 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.447 -0.602 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.055 177.552 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 122.775 1.274 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.793 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.69 148.61 46.56 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.246 -2.252 . . . . 0.0 106.7 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.22 159.78 5.37 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-O 122.569 0.987 . . . . 0.0 113.513 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.59 120.0 7.04 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.187 -2.279 . . . . 0.0 109.061 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.23 1.87 59.28 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 111.362 -2.654 . . . . 0.0 113.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.8 t -69.44 133.93 48.33 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.944 0.878 . . . . 0.0 111.69 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -60.64 125.55 24.11 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.55 -18.29 10.24 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.588 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -71.09 -21.92 62.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.19 -11.72 58.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.673 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.43 147.87 90.26 Favored Pre-proline 0 N--CA 1.431 -1.419 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.372 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.673 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 98.0 Cg_endo -93.16 10.57 54.91 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 120.072 1.061 . . . . 0.0 112.04 -0.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.809 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 2.3 mm-40 -68.83 -37.91 79.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 99.1 m 57.92 40.22 25.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.809 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 8.1 mttm -68.01 115.47 28.78 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 72.6 Cg_exo -43.07 -33.17 3.22 Favored 'Trans proline' 0 CA--C 1.51 -0.679 0 C-N-CA 122.198 1.932 . . . . 0.0 113.021 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.834 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.31 -38.97 94.15 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.875 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.4 t -83.02 -32.99 26.61 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.3 m -65.32 -54.19 32.6 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.858 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.18 -14.7 11.49 Favored Glycine 0 C--N 1.308 -0.974 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.834 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -159.51 118.51 2.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.416 1.608 . . . . 0.0 114.602 -174.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.25 178.047 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.824 1.297 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.46 148.65 47.27 Favored Pre-proline 0 N--CA 1.424 -1.733 0 CA-C-N 112.21 -2.268 . . . . 0.0 106.93 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 Cg_exo -52.75 159.21 5.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.57 0.987 . . . . 0.0 113.484 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 p -56.4 119.63 6.35 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 112.232 -2.258 . . . . 0.0 109.07 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.03 58.9 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 111.445 -2.616 . . . . 0.0 114.027 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 49.3 t -69.61 134.2 48.49 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.047 0.927 . . . . 0.0 112.11 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.5 t -60.63 125.24 22.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 113.765 -1.562 . . . . 0.0 109.46 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.05 -18.68 9.45 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.667 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -21.84 62.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 17.9 m -82.11 -11.51 58.72 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.68 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.25 147.26 90.33 Favored Pre-proline 0 N--CA 1.428 -1.542 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.779 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.68 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 67.3 Cg_endo -93.44 10.57 53.69 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 120.097 1.07 . . . . 0.0 112.261 0.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.44 -38.15 80.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 88.7 m 57.66 38.84 27.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.113 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 115.79 34.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.992 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.5 Cg_exo -42.79 -32.76 2.68 Favored 'Trans proline' 0 CA--C 1.51 -0.715 0 C-N-CA 122.175 1.916 . . . . 0.0 113.174 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.874 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.89 -39.37 93.37 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.839 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.0 t -83.18 -32.7 26.45 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.4 m -65.67 -53.89 34.99 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.865 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.29 -15.23 12.86 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.874 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -159.13 114.8 2.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.111 1.456 . . . . 0.0 113.62 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.458 178.181 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 122.76 1.267 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.786 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.3 m -86.63 149.3 48.37 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.81 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.38 159.76 5.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.688 1.037 . . . . 0.0 113.437 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.54 119.57 6.31 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.115 -2.311 . . . . 0.0 109.167 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.95 1.76 58.43 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 111.43 -2.623 . . . . 0.0 114.105 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.8 t -69.61 133.75 47.95 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.016 0.912 . . . . 0.0 112.014 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.0 t -60.75 126.09 26.12 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.511 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.99 -17.91 10.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.596 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.0 -22.17 62.2 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.5 m -82.01 -12.12 58.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.663 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.31 147.55 90.36 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.418 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.663 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 97.7 Cg_endo -92.58 10.8 56.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 120.018 1.042 . . . . 0.0 112.111 -0.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.746 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 28.0 mm-40 -68.67 -37.97 80.01 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.6 m 57.99 39.71 26.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.746 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 11.0 mttm -68.11 115.64 30.8 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 74.7 Cg_exo -43.33 -33.27 3.85 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 122.146 1.897 . . . . 0.0 113.272 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.86 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.52 -38.72 93.64 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.848 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.18 -33.29 26.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.9 m -65.43 -54.57 26.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.207 -1.36 . . . . 0.0 113.993 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.18 -16.31 12.61 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.86 ' O ' ' O ' ' A' ' 23' ' ' GLY . 6.9 pt20 -159.77 117.92 2.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.033 1.416 . . . . 0.0 114.526 -174.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.9 t . . . . . 0 N--CA 1.445 -0.698 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.337 177.825 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.482 ' HG1' ' H ' ' A' ' 8' ' ' CYS . 8.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 122.765 1.269 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.774 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.76 149.19 47.78 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 112.192 -2.276 . . . . 0.0 106.901 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -53.0 159.6 5.11 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 CA-C-O 122.643 1.018 . . . . 0.0 113.502 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 p -56.67 119.66 6.52 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.205 -2.27 . . . . 0.0 109.165 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.75 1.86 58.65 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 111.346 -2.661 . . . . 0.0 114.112 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 51.9 t -69.56 133.72 47.97 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.067 0.937 . . . . 0.0 112.15 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -60.77 125.84 25.21 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.67 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.58 -18.51 10.74 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.737 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.99 -21.82 62.25 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 117.42 0.61 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.4 m -82.16 -11.77 58.53 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.32 146.31 89.14 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.157 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.613 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 68.3 Cg_endo -93.28 11.08 53.57 Favored 'Cis proline' 0 C--N 1.354 0.851 0 CA-C-N 120.098 1.071 . . . . 0.0 112.276 -0.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.446 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 5.9 mm-40 -68.33 -37.79 80.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 91.0 m 57.69 39.07 27.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.962 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -68.8 114.29 21.72 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.224 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 64.4 Cg_exo -41.92 -33.35 2.07 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.309 2.006 . . . . 0.0 113.259 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.829 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -67.02 -38.86 92.97 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.845 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.32 -33.33 25.94 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.774 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.5 m -65.6 -54.11 32.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 114.207 -1.361 . . . . 0.0 113.87 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.28 -16.28 12.53 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 116.436 1.335 . . . . 0.0 116.436 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.829 ' O ' ' O ' ' A' ' 23' ' ' GLY . 11.1 pt20 -159.26 114.87 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.111 1.456 . . . . 0.0 114.312 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 114.013 -1.448 . . . . 0.0 108.448 177.809 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 122.857 1.313 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.5 149.22 48.55 Favored Pre-proline 0 N--CA 1.424 -1.739 0 CA-C-N 112.284 -2.234 . . . . 0.0 106.897 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -52.76 160.58 3.8 Favored 'Trans proline' 0 N--CA 1.432 -2.113 0 CA-C-O 122.629 1.012 . . . . 0.0 113.625 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -56.72 119.21 5.78 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.151 -2.295 . . . . 0.0 109.134 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.02 58.83 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.268 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 51.9 t -69.22 134.3 49.04 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 122.043 0.925 . . . . 0.0 111.947 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 t -60.8 125.77 24.92 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.677 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.27 -18.43 9.7 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.62 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.29 -22.24 61.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.067 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.27 -11.61 58.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.673 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.4 147.48 90.07 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.108 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.673 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 72.2 Cg_endo -92.78 10.24 56.64 Favored 'Cis proline' 0 C--N 1.354 0.82 0 CA-C-N 120.258 1.128 . . . . 0.0 112.072 -0.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.89 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 3.9 mm-40 -68.5 -38.45 80.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 95.5 m 57.86 38.94 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.89 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 10.7 mttm -68.04 114.51 21.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.1 Cg_exo -42.1 -32.51 1.94 Allowed 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 122.391 2.06 . . . . 0.0 113.08 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.83 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.75 -39.82 93.69 Favored Glycine 0 C--N 1.305 -1.159 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.723 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.94 -32.22 27.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.6 m -65.44 -54.44 28.49 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.941 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.26 -14.59 11.58 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.766 1.466 . . . . 0.0 116.766 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.83 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.1 pt20 -159.69 117.18 2.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.36 1.58 . . . . 0.0 113.951 -175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.724 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.491 ' HG1' ' HE2' ' A' ' 17' ' ' TYR . 10.7 t . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 122.724 1.25 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.78 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.56 149.35 48.67 Favored Pre-proline 0 N--CA 1.423 -1.79 0 CA-C-N 112.306 -2.225 . . . . 0.0 106.694 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.35 160.16 5.19 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-O 122.674 1.031 . . . . 0.0 113.513 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -56.51 119.65 6.43 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.101 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.79 58.88 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.213 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.9 t -69.57 133.88 48.14 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 118.007 0.903 . . . . 0.0 111.973 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -60.78 126.25 26.72 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.617 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.94 -17.76 10.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.646 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -71.21 -22.29 62.03 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 117.44 0.62 . . . . 0.0 111.009 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.7 m -81.97 -11.65 58.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.653 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.27 147.8 90.64 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.553 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.653 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 56.0 Cg_endo -92.89 10.24 56.38 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.044 1.051 . . . . 0.0 112.096 -0.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.571 ' HB2' ' HZ1' ' A' ' 21' ' ' LYS . 1.9 mm-40 -68.52 -37.5 80.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.7 m 57.92 40.13 26.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' A' ' 19' ' ' GLU . 1.6 mtmp? -67.89 114.6 21.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.506 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.9 -32.92 2.85 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.271 1.981 . . . . 0.0 113.192 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.973 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.53 -39.21 93.9 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.737 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.3 t -83.03 -33.0 26.59 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.5 m -65.13 -54.18 33.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.711 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.74 -16.92 10.94 Favored Glycine 0 C--N 1.31 -0.912 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.973 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -160.65 123.02 3.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 114.026 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.447 178.104 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.407 ' HG1' ' HE2' ' A' ' 17' ' ' TYR . 10.1 t . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 122.868 1.318 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.779 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.6 m -86.68 149.46 48.6 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-N 112.288 -2.233 . . . . 0.0 106.978 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.94 159.24 5.41 Favored 'Trans proline' 0 N--CA 1.43 -2.234 0 CA-C-O 122.702 1.043 . . . . 0.0 113.392 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.31 120.32 7.43 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.069 -173.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.29 1.78 59.24 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 111.274 -2.694 . . . . 0.0 114.304 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 51.5 t -69.45 133.75 48.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.094 0.949 . . . . 0.0 112.075 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -61.03 126.31 26.88 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.581 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.67 -17.98 9.98 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.583 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -70.92 -22.54 62.23 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.04 -11.62 58.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.683 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.6 t80 -72.47 147.69 90.03 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.635 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.683 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 46.0 Cg_endo -92.99 10.29 56.03 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.147 1.088 . . . . 0.0 112.02 -0.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.23 -38.29 81.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 89.7 m 57.97 39.6 26.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -67.71 114.93 22.58 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.508 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.79 -32.85 2.71 Favored 'Trans proline' 0 CA--C 1.511 -0.666 0 C-N-CA 122.286 1.991 . . . . 0.0 112.97 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.797 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.03 -39.61 94.84 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.014 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -83.08 -32.25 26.89 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.34 -54.28 31.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.69 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.06 -14.27 10.15 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 116.987 1.555 . . . . 0.0 116.987 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.797 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -159.88 118.89 2.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.537 1.668 . . . . 0.0 114.519 -174.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.443 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 122.811 1.291 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.801 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.4 m -86.52 149.36 48.79 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 112.227 -2.26 . . . . 0.0 106.888 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.1 160.12 4.76 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 CA-C-O 122.631 1.013 . . . . 0.0 113.521 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 p -56.58 119.77 6.65 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.127 -2.306 . . . . 0.0 109.104 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.25 1.97 59.23 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 111.467 -2.606 . . . . 0.0 114.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.0 t -69.42 133.82 48.23 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.035 0.917 . . . . 0.0 112.071 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -60.9 125.8 25.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.574 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.65 -18.46 10.85 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.725 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.09 -21.77 62.18 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.034 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.2 -11.46 58.68 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.659 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.37 147.14 89.91 Favored Pre-proline 0 N--CA 1.428 -1.532 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.062 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.659 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 85.0 Cg_endo -92.91 10.89 55.29 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.188 1.103 . . . . 0.0 112.278 -0.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -68.31 -38.69 81.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 84.3 m 57.58 38.66 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.672 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 113.78 17.87 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 56.8 Cg_exo -41.4 -32.85 1.39 Allowed 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 122.229 1.953 . . . . 0.0 113.18 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.861 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.61 -39.36 93.81 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.868 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.42 -32.72 25.95 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.37 -53.99 35.33 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.871 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.71 -15.55 10.94 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.861 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.9 pt20 -159.95 118.47 2.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.254 1.527 . . . . 0.0 113.73 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.13 106.58 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.577 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.99 82.4 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.14 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 mt -107.18 25.72 11.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.779 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.729 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 122.773 1.273 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.781 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.23 149.23 49.29 Favored Pre-proline 0 N--CA 1.425 -1.697 0 CA-C-N 112.299 -2.228 . . . . 0.0 106.517 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.75 160.93 4.99 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 CA-C-O 122.778 1.074 . . . . 0.0 113.575 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 p -56.64 119.2 5.74 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.98 -2.373 . . . . 0.0 109.228 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.13 59.3 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 111.496 -2.593 . . . . 0.0 114.138 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 50.7 t -69.21 134.28 49.03 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.069 0.938 . . . . 0.0 111.868 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -60.84 125.09 22.41 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.39 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -53.9 -18.37 8.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.516 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -22.01 62.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 117.199 0.499 . . . . 0.0 111.332 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 19.5 m -82.22 -11.25 58.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.635 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.49 147.21 89.65 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.362 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.635 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 96.6 Cg_endo -92.64 11.09 55.54 Favored 'Cis proline' 0 C--N 1.352 0.716 0 CA-C-N 120.13 1.082 . . . . 0.0 112.145 -0.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 23.2 mt-10 -68.17 -38.7 82.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 92.8 m 57.67 38.31 27.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.876 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -68.6 114.76 24.26 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 60.2 Cg_exo -42.54 -31.95 2.12 Favored 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.19 1.927 . . . . 0.0 113.058 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.51 -39.87 94.12 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.905 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.9 t -83.55 -32.34 25.91 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.0 m -65.47 -53.31 44.52 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.0 -1.455 . . . . 0.0 113.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.42 -15.36 8.95 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.705 ' O ' ' O ' ' A' ' 23' ' ' GLY . 7.3 pt20 -160.84 119.21 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.638 1.719 . . . . 0.0 115.159 -174.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -96.95 105.5 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.25 52.57 0.72 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.1 20.24 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.962 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 122.817 1.294 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.77 149.29 47.98 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 112.223 -2.262 . . . . 0.0 106.906 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.38 160.42 4.94 Favored 'Trans proline' 0 N--CA 1.431 -2.179 0 CA-C-O 122.725 1.052 . . . . 0.0 113.506 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -56.57 119.76 6.64 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.156 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.49 1.77 58.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 111.495 -2.593 . . . . 0.0 114.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.9 t -69.69 133.78 47.92 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.056 0.931 . . . . 0.0 112.201 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -60.82 126.48 27.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.621 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.97 -17.85 10.49 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.649 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.2 -22.48 62.01 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 15.1 m -81.97 -11.53 58.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.24 147.4 90.47 Favored Pre-proline 0 N--CA 1.432 -1.366 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.632 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.3 Cg_endo -92.38 11.03 56.26 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.115 1.077 . . . . 0.0 111.868 -0.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.95 -38.97 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 85.7 m 57.91 38.55 27.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.697 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -68.11 114.82 23.2 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 73.5 Cg_exo -43.04 -32.35 2.76 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.242 1.961 . . . . 0.0 113.151 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.914 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.77 -39.81 93.66 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.157 -1.02 . . . . 0.0 111.677 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 t -82.99 -32.73 26.82 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -65.29 -54.14 33.52 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.783 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.45 -16.04 10.69 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.914 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 pt20 -160.93 123.96 3.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.373 1.586 . . . . 0.0 114.727 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 t -100.72 106.69 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.055 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.73 78.88 1.16 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.116 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.11 18.81 10.12 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.719 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.914 179.76 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 122.775 1.274 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.793 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.69 148.61 46.56 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.246 -2.252 . . . . 0.0 106.7 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.22 159.78 5.37 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-O 122.569 0.987 . . . . 0.0 113.513 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.59 120.0 7.04 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.187 -2.279 . . . . 0.0 109.061 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.23 1.87 59.28 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 111.362 -2.654 . . . . 0.0 113.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.8 t -69.44 133.93 48.33 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.944 0.878 . . . . 0.0 111.69 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -60.64 125.55 24.11 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.55 -18.29 10.24 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.588 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -71.09 -21.92 62.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.19 -11.72 58.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.673 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.43 147.87 90.26 Favored Pre-proline 0 N--CA 1.431 -1.419 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.372 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.673 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 98.0 Cg_endo -93.16 10.57 54.91 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 120.072 1.061 . . . . 0.0 112.04 -0.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.809 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 2.3 mm-40 -68.83 -37.91 79.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 99.1 m 57.92 40.22 25.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.809 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 8.1 mttm -68.01 115.47 28.78 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 72.6 Cg_exo -43.07 -33.17 3.22 Favored 'Trans proline' 0 CA--C 1.51 -0.679 0 C-N-CA 122.198 1.932 . . . . 0.0 113.021 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.834 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.31 -38.97 94.15 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.875 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.4 t -83.02 -32.99 26.61 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.3 m -65.32 -54.19 32.6 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.858 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.18 -14.7 11.49 Favored Glycine 0 C--N 1.308 -0.974 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.834 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -159.51 118.51 2.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.416 1.608 . . . . 0.0 114.602 -174.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.92 107.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.25 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.92 83.1 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.977 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 tp -94.69 17.77 12.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.347 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.656 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.824 1.297 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.46 148.65 47.27 Favored Pre-proline 0 N--CA 1.424 -1.733 0 CA-C-N 112.21 -2.268 . . . . 0.0 106.93 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 Cg_exo -52.75 159.21 5.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.57 0.987 . . . . 0.0 113.484 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 p -56.4 119.63 6.35 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 112.232 -2.258 . . . . 0.0 109.07 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.03 58.9 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 111.445 -2.616 . . . . 0.0 114.027 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 49.3 t -69.61 134.2 48.49 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.047 0.927 . . . . 0.0 112.11 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.5 t -60.63 125.24 22.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 113.765 -1.562 . . . . 0.0 109.46 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.05 -18.68 9.45 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.667 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -21.84 62.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 17.9 m -82.11 -11.51 58.72 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.68 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.25 147.26 90.33 Favored Pre-proline 0 N--CA 1.428 -1.542 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.779 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.68 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 67.3 Cg_endo -93.44 10.57 53.69 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 120.097 1.07 . . . . 0.0 112.261 0.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.44 -38.15 80.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 88.7 m 57.66 38.84 27.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.113 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 115.79 34.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.992 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.5 Cg_exo -42.79 -32.76 2.68 Favored 'Trans proline' 0 CA--C 1.51 -0.715 0 C-N-CA 122.175 1.916 . . . . 0.0 113.174 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.874 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.89 -39.37 93.37 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.839 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.0 t -83.18 -32.7 26.45 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.4 m -65.67 -53.89 34.99 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.865 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.29 -15.23 12.86 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.874 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -159.13 114.8 2.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.111 1.456 . . . . 0.0 113.62 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.57 108.24 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.458 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.13 81.32 0.13 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.475 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.456 HD13 ' OXT' ' A' ' 31' ' ' ASN . 2.4 pp -76.34 -0.33 22.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.69 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OXT' HD13 ' A' ' 30' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.991 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 122.76 1.267 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.786 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.3 m -86.63 149.3 48.37 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.81 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.38 159.76 5.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.688 1.037 . . . . 0.0 113.437 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.54 119.57 6.31 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.115 -2.311 . . . . 0.0 109.167 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.95 1.76 58.43 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 111.43 -2.623 . . . . 0.0 114.105 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.8 t -69.61 133.75 47.95 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.016 0.912 . . . . 0.0 112.014 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.0 t -60.75 126.09 26.12 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.511 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.99 -17.91 10.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.596 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.0 -22.17 62.2 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.5 m -82.01 -12.12 58.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.663 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.31 147.55 90.36 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.418 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.663 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 97.7 Cg_endo -92.58 10.8 56.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 120.018 1.042 . . . . 0.0 112.111 -0.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.746 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 28.0 mm-40 -68.67 -37.97 80.01 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.6 m 57.99 39.71 26.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.746 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 11.0 mttm -68.11 115.64 30.8 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 74.7 Cg_exo -43.33 -33.27 3.85 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 122.146 1.897 . . . . 0.0 113.272 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.86 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.52 -38.72 93.64 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.848 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.18 -33.29 26.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.9 m -65.43 -54.57 26.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.207 -1.36 . . . . 0.0 113.993 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.18 -16.31 12.61 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.86 ' O ' ' O ' ' A' ' 23' ' ' GLY . 6.9 pt20 -159.77 117.92 2.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.033 1.416 . . . . 0.0 114.526 -174.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.9 t -105.81 109.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.337 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.13 81.71 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.715 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -98.46 20.27 13.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.896 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.88 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.482 ' HG1' ' H ' ' A' ' 8' ' ' CYS . 8.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 122.765 1.269 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.774 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.76 149.19 47.78 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 112.192 -2.276 . . . . 0.0 106.901 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -53.0 159.6 5.11 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 CA-C-O 122.643 1.018 . . . . 0.0 113.502 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 p -56.67 119.66 6.52 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.205 -2.27 . . . . 0.0 109.165 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.75 1.86 58.65 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 111.346 -2.661 . . . . 0.0 114.112 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 51.9 t -69.56 133.72 47.97 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.067 0.937 . . . . 0.0 112.15 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -60.77 125.84 25.21 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.67 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.58 -18.51 10.74 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.737 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.99 -21.82 62.25 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 117.42 0.61 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.4 m -82.16 -11.77 58.53 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.32 146.31 89.14 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.157 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.613 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 68.3 Cg_endo -93.28 11.08 53.57 Favored 'Cis proline' 0 C--N 1.354 0.851 0 CA-C-N 120.098 1.071 . . . . 0.0 112.276 -0.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.446 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 5.9 mm-40 -68.33 -37.79 80.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 91.0 m 57.69 39.07 27.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.962 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -68.8 114.29 21.72 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.224 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 64.4 Cg_exo -41.92 -33.35 2.07 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.309 2.006 . . . . 0.0 113.259 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.829 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -67.02 -38.86 92.97 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.845 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.32 -33.33 25.94 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.774 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.5 m -65.6 -54.11 32.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 114.207 -1.361 . . . . 0.0 113.87 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.28 -16.28 12.53 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 116.436 1.335 . . . . 0.0 116.436 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.829 ' O ' ' O ' ' A' ' 23' ' ' GLY . 11.1 pt20 -159.26 114.87 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.111 1.456 . . . . 0.0 114.312 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -105.22 109.93 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.013 -1.448 . . . . 0.0 108.448 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.37 80.42 0.12 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.787 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.66 21.08 12.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.675 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.757 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 122.857 1.313 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.5 149.22 48.55 Favored Pre-proline 0 N--CA 1.424 -1.739 0 CA-C-N 112.284 -2.234 . . . . 0.0 106.897 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -52.76 160.58 3.8 Favored 'Trans proline' 0 N--CA 1.432 -2.113 0 CA-C-O 122.629 1.012 . . . . 0.0 113.625 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -56.72 119.21 5.78 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.151 -2.295 . . . . 0.0 109.134 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.02 58.83 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.268 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 51.9 t -69.22 134.3 49.04 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 122.043 0.925 . . . . 0.0 111.947 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 t -60.8 125.77 24.92 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.677 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.27 -18.43 9.7 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.62 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.29 -22.24 61.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.067 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.27 -11.61 58.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.673 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.4 147.48 90.07 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.108 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.673 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 72.2 Cg_endo -92.78 10.24 56.64 Favored 'Cis proline' 0 C--N 1.354 0.82 0 CA-C-N 120.258 1.128 . . . . 0.0 112.072 -0.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.89 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 3.9 mm-40 -68.5 -38.45 80.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 95.5 m 57.86 38.94 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.89 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 10.7 mttm -68.04 114.51 21.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.1 Cg_exo -42.1 -32.51 1.94 Allowed 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 122.391 2.06 . . . . 0.0 113.08 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.83 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.75 -39.82 93.69 Favored Glycine 0 C--N 1.305 -1.159 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.723 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.94 -32.22 27.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.6 m -65.44 -54.44 28.49 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.941 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.26 -14.59 11.58 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.766 1.466 . . . . 0.0 116.766 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.83 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.1 pt20 -159.69 117.18 2.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.36 1.58 . . . . 0.0 113.951 -175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 t -94.9 106.62 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.99 53.39 0.75 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.708 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -97.32 18.61 14.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.182 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.209 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.491 ' HG1' ' HE2' ' A' ' 17' ' ' TYR . 10.7 t . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 122.724 1.25 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.78 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.56 149.35 48.67 Favored Pre-proline 0 N--CA 1.423 -1.79 0 CA-C-N 112.306 -2.225 . . . . 0.0 106.694 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.35 160.16 5.19 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-O 122.674 1.031 . . . . 0.0 113.513 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -56.51 119.65 6.43 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.101 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.79 58.88 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.213 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.9 t -69.57 133.88 48.14 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 118.007 0.903 . . . . 0.0 111.973 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -60.78 126.25 26.72 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.617 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.94 -17.76 10.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.646 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -71.21 -22.29 62.03 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 117.44 0.62 . . . . 0.0 111.009 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.7 m -81.97 -11.65 58.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.653 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.27 147.8 90.64 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.553 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.653 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 56.0 Cg_endo -92.89 10.24 56.38 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.044 1.051 . . . . 0.0 112.096 -0.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.571 ' HB2' ' HZ1' ' A' ' 21' ' ' LYS . 1.9 mm-40 -68.52 -37.5 80.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.7 m 57.92 40.13 26.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' A' ' 19' ' ' GLU . 1.6 mtmp? -67.89 114.6 21.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.506 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.9 -32.92 2.85 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.271 1.981 . . . . 0.0 113.192 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.973 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.53 -39.21 93.9 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.737 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.3 t -83.03 -33.0 26.59 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.5 m -65.13 -54.18 33.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.711 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.74 -16.92 10.94 Favored Glycine 0 C--N 1.31 -0.912 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.973 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -160.65 123.02 3.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 114.026 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.4 106.49 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.447 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.54 71.18 0.74 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.095 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.83 18.01 12.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.847 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.792 179.755 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.407 ' HG1' ' HE2' ' A' ' 17' ' ' TYR . 10.1 t . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 122.868 1.318 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.779 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.6 m -86.68 149.46 48.6 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-N 112.288 -2.233 . . . . 0.0 106.978 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.94 159.24 5.41 Favored 'Trans proline' 0 N--CA 1.43 -2.234 0 CA-C-O 122.702 1.043 . . . . 0.0 113.392 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.31 120.32 7.43 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.069 -173.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.29 1.78 59.24 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 111.274 -2.694 . . . . 0.0 114.304 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 51.5 t -69.45 133.75 48.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.094 0.949 . . . . 0.0 112.075 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -61.03 126.31 26.88 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.581 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.67 -17.98 9.98 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.583 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -70.92 -22.54 62.23 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.04 -11.62 58.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.683 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.6 t80 -72.47 147.69 90.03 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.635 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.683 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 46.0 Cg_endo -92.99 10.29 56.03 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.147 1.088 . . . . 0.0 112.02 -0.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.23 -38.29 81.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 89.7 m 57.97 39.6 26.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -67.71 114.93 22.58 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.508 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.79 -32.85 2.71 Favored 'Trans proline' 0 CA--C 1.511 -0.666 0 C-N-CA 122.286 1.991 . . . . 0.0 112.97 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.797 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.03 -39.61 94.84 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.014 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -83.08 -32.25 26.89 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.34 -54.28 31.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.69 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.06 -14.27 10.15 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 116.987 1.555 . . . . 0.0 116.987 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.797 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -159.88 118.89 2.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.537 1.668 . . . . 0.0 114.519 -174.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 t -97.57 105.56 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.11 56.46 0.62 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.262 0.553 . . . . 0.0 109.926 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.99 13.94 13.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.965 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.892 -179.69 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' CYS . 12.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 122.811 1.291 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.4 m -86.52 149.36 48.79 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 112.227 -2.26 . . . . 0.0 106.888 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.1 160.12 4.76 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 CA-C-O 122.631 1.013 . . . . 0.0 113.521 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 p -56.58 119.77 6.65 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.127 -2.306 . . . . 0.0 109.104 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.25 1.97 59.23 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 111.467 -2.606 . . . . 0.0 114.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 52.0 t -69.42 133.82 48.23 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.035 0.917 . . . . 0.0 112.071 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -60.9 125.8 25.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.574 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.65 -18.46 10.85 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.725 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.09 -21.77 62.18 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.034 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.2 -11.46 58.68 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.37 147.14 89.91 Favored Pre-proline 0 N--CA 1.428 -1.532 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.062 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 85.0 Cg_endo -92.91 10.89 55.29 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.188 1.103 . . . . 0.0 112.278 -0.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -68.31 -38.69 81.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 84.3 m 57.58 38.66 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.672 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 113.78 17.87 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 56.8 Cg_exo -41.4 -32.85 1.39 Allowed 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 122.229 1.953 . . . . 0.0 113.18 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.861 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.61 -39.36 93.81 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.868 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.42 -32.72 25.95 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.37 -53.99 35.33 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.871 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.71 -15.55 10.94 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.861 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.9 pt20 -159.95 118.47 2.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.254 1.527 . . . . 0.0 113.73 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 N--CA 1.443 -0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.577 178.168 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 8' ' ' CYS . 11.4 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 122.773 1.273 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.811 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.23 149.23 49.29 Favored Pre-proline 0 N--CA 1.425 -1.697 0 CA-C-N 112.299 -2.228 . . . . 0.0 106.517 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.75 160.93 4.99 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 CA-C-O 122.778 1.074 . . . . 0.0 113.575 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 p -56.64 119.2 5.74 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.98 -2.373 . . . . 0.0 109.228 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.13 59.3 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 111.496 -2.593 . . . . 0.0 114.138 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 50.7 t -69.21 134.28 49.03 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.069 0.938 . . . . 0.0 111.868 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -60.84 125.09 22.41 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.39 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -53.9 -18.37 8.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.516 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -22.01 62.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 117.199 0.499 . . . . 0.0 111.332 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 19.5 m -82.22 -11.25 58.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.561 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.49 147.21 89.65 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.362 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 96.6 Cg_endo -92.64 11.09 55.54 Favored 'Cis proline' 0 C--N 1.352 0.716 0 CA-C-N 120.13 1.082 . . . . 0.0 112.145 -0.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 23.2 mt-10 -68.17 -38.7 82.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 92.8 m 57.67 38.31 27.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.876 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -68.6 114.76 24.26 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 60.2 Cg_exo -42.54 -31.95 2.12 Favored 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.19 1.927 . . . . 0.0 113.058 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.51 -39.87 94.12 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.905 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.9 t -83.55 -32.34 25.91 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.811 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.0 m -65.47 -53.31 44.52 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.0 -1.455 . . . . 0.0 113.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.42 -15.36 8.95 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.705 ' O ' ' O ' ' A' ' 23' ' ' GLY . 7.3 pt20 -160.84 119.21 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.638 1.719 . . . . 0.0 115.159 -174.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 CA--C 1.519 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.753 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 8' ' ' CYS . 7.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 122.817 1.294 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.804 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.77 149.29 47.98 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 112.223 -2.262 . . . . 0.0 106.906 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.38 160.42 4.94 Favored 'Trans proline' 0 N--CA 1.431 -2.179 0 CA-C-O 122.725 1.052 . . . . 0.0 113.506 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -56.57 119.76 6.64 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.156 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.49 1.77 58.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 111.495 -2.593 . . . . 0.0 114.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 52.9 t -69.69 133.78 47.92 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.056 0.931 . . . . 0.0 112.201 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -60.82 126.48 27.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.621 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.97 -17.85 10.49 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.649 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.2 -22.48 62.01 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 15.1 m -81.97 -11.53 58.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.24 147.4 90.47 Favored Pre-proline 0 N--CA 1.432 -1.366 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.3 Cg_endo -92.38 11.03 56.26 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.115 1.077 . . . . 0.0 111.868 -0.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.95 -38.97 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 85.7 m 57.91 38.55 27.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.697 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -68.11 114.82 23.2 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 73.5 Cg_exo -43.04 -32.35 2.76 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.242 1.961 . . . . 0.0 113.151 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.914 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.77 -39.81 93.66 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.157 -1.02 . . . . 0.0 111.677 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 t -82.99 -32.73 26.82 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -65.29 -54.14 33.52 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.783 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.45 -16.04 10.69 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.914 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 pt20 -160.93 123.96 3.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.373 1.586 . . . . 0.0 114.727 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.447 -0.602 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.055 177.552 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 8' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 122.775 1.274 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.823 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.69 148.61 46.56 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.246 -2.252 . . . . 0.0 106.7 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.22 159.78 5.37 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-O 122.569 0.987 . . . . 0.0 113.513 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.59 120.0 7.04 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.187 -2.279 . . . . 0.0 109.061 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.23 1.87 59.28 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 111.362 -2.654 . . . . 0.0 113.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.8 t -69.44 133.93 48.33 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.944 0.878 . . . . 0.0 111.69 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -60.64 125.55 24.11 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.55 -18.29 10.24 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.588 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -71.09 -21.92 62.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.19 -11.72 58.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.601 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.43 147.87 90.26 Favored Pre-proline 0 N--CA 1.431 -1.419 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.372 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 98.0 Cg_endo -93.16 10.57 54.91 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 120.072 1.061 . . . . 0.0 112.04 -0.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.855 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 2.3 mm-40 -68.83 -37.91 79.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 99.1 m 57.92 40.22 25.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.855 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 8.1 mttm -68.01 115.47 28.78 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 72.6 Cg_exo -43.07 -33.17 3.22 Favored 'Trans proline' 0 CA--C 1.51 -0.679 0 C-N-CA 122.198 1.932 . . . . 0.0 113.021 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.834 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.31 -38.97 94.15 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.875 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.4 t -83.02 -32.99 26.61 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.823 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.3 m -65.32 -54.19 32.6 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.858 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.18 -14.7 11.49 Favored Glycine 0 C--N 1.308 -0.974 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.834 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -159.51 118.51 2.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.416 1.608 . . . . 0.0 114.602 -174.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.25 178.047 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' CYS . 7.4 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.824 1.297 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.46 148.65 47.27 Favored Pre-proline 0 N--CA 1.424 -1.733 0 CA-C-N 112.21 -2.268 . . . . 0.0 106.93 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 Cg_exo -52.75 159.21 5.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.57 0.987 . . . . 0.0 113.484 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 p -56.4 119.63 6.35 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 112.232 -2.258 . . . . 0.0 109.07 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.03 58.9 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 111.445 -2.616 . . . . 0.0 114.027 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 49.3 t -69.61 134.2 48.49 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.047 0.927 . . . . 0.0 112.11 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.5 t -60.63 125.24 22.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 113.765 -1.562 . . . . 0.0 109.46 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.05 -18.68 9.45 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.667 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -21.84 62.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 17.9 m -82.11 -11.51 58.72 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.25 147.26 90.33 Favored Pre-proline 0 N--CA 1.428 -1.542 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.779 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 67.3 Cg_endo -93.44 10.57 53.69 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 120.097 1.07 . . . . 0.0 112.261 0.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.44 -38.15 80.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 88.7 m 57.66 38.84 27.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.113 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 115.79 34.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.992 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.5 Cg_exo -42.79 -32.76 2.68 Favored 'Trans proline' 0 CA--C 1.51 -0.715 0 C-N-CA 122.175 1.916 . . . . 0.0 113.174 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.874 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.89 -39.37 93.37 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.839 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.0 t -83.18 -32.7 26.45 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.4 m -65.67 -53.89 34.99 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.865 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.29 -15.23 12.86 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.874 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -159.13 114.8 2.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.111 1.456 . . . . 0.0 113.62 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.458 178.181 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 122.76 1.267 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.3 m -86.63 149.3 48.37 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.81 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.38 159.76 5.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.688 1.037 . . . . 0.0 113.437 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.54 119.57 6.31 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.115 -2.311 . . . . 0.0 109.167 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.95 1.76 58.43 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 111.43 -2.623 . . . . 0.0 114.105 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 53.8 t -69.61 133.75 47.95 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.016 0.912 . . . . 0.0 112.014 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.0 t -60.75 126.09 26.12 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.511 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.99 -17.91 10.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.596 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.0 -22.17 62.2 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.5 m -82.01 -12.12 58.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.31 147.55 90.36 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.418 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 97.7 Cg_endo -92.58 10.8 56.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 120.018 1.042 . . . . 0.0 112.111 -0.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -68.67 -37.97 80.01 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.6 m 57.99 39.71 26.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG3' ' HZ3' ' A' ' 21' ' ' LYS . 11.0 mttm -68.11 115.64 30.8 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 74.7 Cg_exo -43.33 -33.27 3.85 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 122.146 1.897 . . . . 0.0 113.272 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.86 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.52 -38.72 93.64 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.848 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.18 -33.29 26.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.9 m -65.43 -54.57 26.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.207 -1.36 . . . . 0.0 113.993 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.18 -16.31 12.61 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.86 ' O ' ' O ' ' A' ' 23' ' ' GLY . 6.9 pt20 -159.77 117.92 2.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.033 1.416 . . . . 0.0 114.526 -174.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.9 t . . . . . 0 N--CA 1.445 -0.698 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.337 177.825 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 8' ' ' CYS . 8.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 122.765 1.269 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.804 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.76 149.19 47.78 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 112.192 -2.276 . . . . 0.0 106.901 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -53.0 159.6 5.11 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 CA-C-O 122.643 1.018 . . . . 0.0 113.502 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 p -56.67 119.66 6.52 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.205 -2.27 . . . . 0.0 109.165 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.75 1.86 58.65 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 111.346 -2.661 . . . . 0.0 114.112 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.9 t -69.56 133.72 47.97 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.067 0.937 . . . . 0.0 112.15 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -60.77 125.84 25.21 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.67 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.58 -18.51 10.74 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.737 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.99 -21.82 62.25 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 117.42 0.61 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.4 m -82.16 -11.77 58.53 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.32 146.31 89.14 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.157 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 68.3 Cg_endo -93.28 11.08 53.57 Favored 'Cis proline' 0 C--N 1.354 0.851 0 CA-C-N 120.098 1.071 . . . . 0.0 112.276 -0.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 5.9 mm-40 -68.33 -37.79 80.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 91.0 m 57.69 39.07 27.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.962 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -68.8 114.29 21.72 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.224 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 64.4 Cg_exo -41.92 -33.35 2.07 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.309 2.006 . . . . 0.0 113.259 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.829 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -67.02 -38.86 92.97 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.845 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.32 -33.33 25.94 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.5 m -65.6 -54.11 32.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 114.207 -1.361 . . . . 0.0 113.87 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.28 -16.28 12.53 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 116.436 1.335 . . . . 0.0 116.436 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.829 ' O ' ' O ' ' A' ' 23' ' ' GLY . 11.1 pt20 -159.26 114.87 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.111 1.456 . . . . 0.0 114.312 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 114.013 -1.448 . . . . 0.0 108.448 177.809 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 122.857 1.313 . . . . 0.0 112.431 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.5 149.22 48.55 Favored Pre-proline 0 N--CA 1.424 -1.739 0 CA-C-N 112.284 -2.234 . . . . 0.0 106.897 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -52.76 160.58 3.8 Favored 'Trans proline' 0 N--CA 1.432 -2.113 0 CA-C-O 122.629 1.012 . . . . 0.0 113.625 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -56.72 119.21 5.78 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.151 -2.295 . . . . 0.0 109.134 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.02 58.83 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.268 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.9 t -69.22 134.3 49.04 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 122.043 0.925 . . . . 0.0 111.947 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 t -60.8 125.77 24.92 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.677 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.27 -18.43 9.7 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.62 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.29 -22.24 61.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.067 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.27 -11.61 58.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.4 147.48 90.07 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.108 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 72.2 Cg_endo -92.78 10.24 56.64 Favored 'Cis proline' 0 C--N 1.354 0.82 0 CA-C-N 120.258 1.128 . . . . 0.0 112.072 -0.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.876 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 3.9 mm-40 -68.5 -38.45 80.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 95.5 m 57.86 38.94 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.876 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 10.7 mttm -68.04 114.51 21.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.1 Cg_exo -42.1 -32.51 1.94 Allowed 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 122.391 2.06 . . . . 0.0 113.08 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.83 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.75 -39.82 93.69 Favored Glycine 0 C--N 1.305 -1.159 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.723 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.94 -32.22 27.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.6 m -65.44 -54.44 28.49 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.941 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.26 -14.59 11.58 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.766 1.466 . . . . 0.0 116.766 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.83 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.1 pt20 -159.69 117.18 2.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.36 1.58 . . . . 0.0 113.951 -175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.724 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.7 t . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 122.724 1.25 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.808 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.56 149.35 48.67 Favored Pre-proline 0 N--CA 1.423 -1.79 0 CA-C-N 112.306 -2.225 . . . . 0.0 106.694 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.35 160.16 5.19 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-O 122.674 1.031 . . . . 0.0 113.513 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -56.51 119.65 6.43 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.101 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.79 58.88 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.213 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t -69.57 133.88 48.14 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 118.007 0.903 . . . . 0.0 111.973 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -60.78 126.25 26.72 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.617 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.94 -17.76 10.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.646 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -71.21 -22.29 62.03 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 117.44 0.62 . . . . 0.0 111.009 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.7 m -81.97 -11.65 58.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.27 147.8 90.64 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.553 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 56.0 Cg_endo -92.89 10.24 56.38 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.044 1.051 . . . . 0.0 112.096 -0.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.52 -37.5 80.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.7 m 57.92 40.13 26.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 21' ' ' LYS . 1.6 mtmp? -67.89 114.6 21.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.9 -32.92 2.85 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.271 1.981 . . . . 0.0 113.192 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.973 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.53 -39.21 93.9 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.737 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.3 t -83.03 -33.0 26.59 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.808 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.5 m -65.13 -54.18 33.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.711 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.74 -16.92 10.94 Favored Glycine 0 C--N 1.31 -0.912 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.973 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -160.65 123.02 3.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 114.026 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.447 178.104 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.1 t . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 122.868 1.318 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.808 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.6 m -86.68 149.46 48.6 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-N 112.288 -2.233 . . . . 0.0 106.978 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.3 Cg_exo -52.94 159.24 5.41 Favored 'Trans proline' 0 N--CA 1.43 -2.234 0 CA-C-O 122.702 1.043 . . . . 0.0 113.392 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.31 120.32 7.43 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.069 -173.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.29 1.78 59.24 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 111.274 -2.694 . . . . 0.0 114.304 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.5 t -69.45 133.75 48.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.094 0.949 . . . . 0.0 112.075 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -61.03 126.31 26.88 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.581 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.67 -17.98 9.98 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.583 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -70.92 -22.54 62.23 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.04 -11.62 58.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.6 t80 -72.47 147.69 90.03 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.635 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 46.0 Cg_endo -92.99 10.29 56.03 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.147 1.088 . . . . 0.0 112.02 -0.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.23 -38.29 81.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 89.7 m 57.97 39.6 26.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -67.71 114.93 22.58 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.79 -32.85 2.71 Favored 'Trans proline' 0 CA--C 1.511 -0.666 0 C-N-CA 122.286 1.991 . . . . 0.0 112.97 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.797 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.03 -39.61 94.84 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.014 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -83.08 -32.25 26.89 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.808 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.34 -54.28 31.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.69 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.06 -14.27 10.15 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 116.987 1.555 . . . . 0.0 116.987 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.797 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -159.88 118.89 2.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.537 1.668 . . . . 0.0 114.519 -174.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.443 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' CYS . 12.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 122.811 1.291 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.4 m -86.52 149.36 48.79 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 112.227 -2.26 . . . . 0.0 106.888 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.1 160.12 4.76 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 CA-C-O 122.631 1.013 . . . . 0.0 113.521 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 p -56.58 119.77 6.65 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.127 -2.306 . . . . 0.0 109.104 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.25 1.97 59.23 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 111.467 -2.606 . . . . 0.0 114.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 52.0 t -69.42 133.82 48.23 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.035 0.917 . . . . 0.0 112.071 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -60.9 125.8 25.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.574 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.65 -18.46 10.85 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.725 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.09 -21.77 62.18 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.034 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.2 -11.46 58.68 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.37 147.14 89.91 Favored Pre-proline 0 N--CA 1.428 -1.532 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.062 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 85.0 Cg_endo -92.91 10.89 55.29 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.188 1.103 . . . . 0.0 112.278 -0.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -68.31 -38.69 81.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 84.3 m 57.58 38.66 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.672 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 113.78 17.87 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 56.8 Cg_exo -41.4 -32.85 1.39 Allowed 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 122.229 1.953 . . . . 0.0 113.18 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.861 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.61 -39.36 93.81 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.868 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.42 -32.72 25.95 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.37 -53.99 35.33 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.871 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.71 -15.55 10.94 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.861 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.9 pt20 -159.95 118.47 2.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.254 1.527 . . . . 0.0 113.73 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.13 106.58 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.577 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -172.99 82.4 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.14 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 mt -107.18 25.72 11.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.779 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.729 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 8' ' ' CYS . 11.4 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 122.773 1.273 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.811 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.23 149.23 49.29 Favored Pre-proline 0 N--CA 1.425 -1.697 0 CA-C-N 112.299 -2.228 . . . . 0.0 106.517 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.75 160.93 4.99 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 CA-C-O 122.778 1.074 . . . . 0.0 113.575 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 p -56.64 119.2 5.74 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.98 -2.373 . . . . 0.0 109.228 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.13 59.3 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 111.496 -2.593 . . . . 0.0 114.138 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 50.7 t -69.21 134.28 49.03 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.069 0.938 . . . . 0.0 111.868 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -60.84 125.09 22.41 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.39 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -53.9 -18.37 8.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.516 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -22.01 62.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 117.199 0.499 . . . . 0.0 111.332 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 19.5 m -82.22 -11.25 58.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.561 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.49 147.21 89.65 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.362 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 96.6 Cg_endo -92.64 11.09 55.54 Favored 'Cis proline' 0 C--N 1.352 0.716 0 CA-C-N 120.13 1.082 . . . . 0.0 112.145 -0.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 23.2 mt-10 -68.17 -38.7 82.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 92.8 m 57.67 38.31 27.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.876 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -68.6 114.76 24.26 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 60.2 Cg_exo -42.54 -31.95 2.12 Favored 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.19 1.927 . . . . 0.0 113.058 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.51 -39.87 94.12 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.905 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.9 t -83.55 -32.34 25.91 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.811 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.0 m -65.47 -53.31 44.52 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.0 -1.455 . . . . 0.0 113.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.42 -15.36 8.95 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.705 ' O ' ' O ' ' A' ' 23' ' ' GLY . 7.3 pt20 -160.84 119.21 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.638 1.719 . . . . 0.0 115.159 -174.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -96.95 105.5 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -110.25 52.57 0.72 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.1 20.24 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.962 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 8' ' ' CYS . 7.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 122.817 1.294 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.804 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.77 149.29 47.98 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 112.223 -2.262 . . . . 0.0 106.906 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.38 160.42 4.94 Favored 'Trans proline' 0 N--CA 1.431 -2.179 0 CA-C-O 122.725 1.052 . . . . 0.0 113.506 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -56.57 119.76 6.64 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.156 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.49 1.77 58.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 111.495 -2.593 . . . . 0.0 114.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 52.9 t -69.69 133.78 47.92 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.056 0.931 . . . . 0.0 112.201 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -60.82 126.48 27.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.621 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.97 -17.85 10.49 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.649 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.2 -22.48 62.01 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 15.1 m -81.97 -11.53 58.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.24 147.4 90.47 Favored Pre-proline 0 N--CA 1.432 -1.366 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.3 Cg_endo -92.38 11.03 56.26 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.115 1.077 . . . . 0.0 111.868 -0.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.95 -38.97 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 85.7 m 57.91 38.55 27.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.697 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -68.11 114.82 23.2 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 73.5 Cg_exo -43.04 -32.35 2.76 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.242 1.961 . . . . 0.0 113.151 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.914 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.77 -39.81 93.66 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.157 -1.02 . . . . 0.0 111.677 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 t -82.99 -32.73 26.82 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -65.29 -54.14 33.52 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.783 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.45 -16.04 10.69 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.914 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 pt20 -160.93 123.96 3.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.373 1.586 . . . . 0.0 114.727 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 t -100.72 106.69 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.055 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -111.73 78.88 1.16 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.116 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.11 18.81 10.12 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.719 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.914 179.76 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 8' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 122.775 1.274 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.823 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.69 148.61 46.56 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.246 -2.252 . . . . 0.0 106.7 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.22 159.78 5.37 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-O 122.569 0.987 . . . . 0.0 113.513 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.59 120.0 7.04 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.187 -2.279 . . . . 0.0 109.061 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.23 1.87 59.28 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 111.362 -2.654 . . . . 0.0 113.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.8 t -69.44 133.93 48.33 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.944 0.878 . . . . 0.0 111.69 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -60.64 125.55 24.11 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.55 -18.29 10.24 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.588 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -71.09 -21.92 62.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.19 -11.72 58.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.601 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.43 147.87 90.26 Favored Pre-proline 0 N--CA 1.431 -1.419 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.372 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 98.0 Cg_endo -93.16 10.57 54.91 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 120.072 1.061 . . . . 0.0 112.04 -0.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.855 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 2.3 mm-40 -68.83 -37.91 79.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 99.1 m 57.92 40.22 25.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.855 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 8.1 mttm -68.01 115.47 28.78 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 72.6 Cg_exo -43.07 -33.17 3.22 Favored 'Trans proline' 0 CA--C 1.51 -0.679 0 C-N-CA 122.198 1.932 . . . . 0.0 113.021 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.834 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.31 -38.97 94.15 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.875 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.4 t -83.02 -32.99 26.61 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.823 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.3 m -65.32 -54.19 32.6 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.858 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.18 -14.7 11.49 Favored Glycine 0 C--N 1.308 -0.974 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.834 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -159.51 118.51 2.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.416 1.608 . . . . 0.0 114.602 -174.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.92 107.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.25 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -174.92 83.1 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.977 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 tp -94.69 17.77 12.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.347 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.656 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' CYS . 7.4 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.824 1.297 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.46 148.65 47.27 Favored Pre-proline 0 N--CA 1.424 -1.733 0 CA-C-N 112.21 -2.268 . . . . 0.0 106.93 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 Cg_exo -52.75 159.21 5.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.57 0.987 . . . . 0.0 113.484 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 p -56.4 119.63 6.35 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 112.232 -2.258 . . . . 0.0 109.07 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.03 58.9 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 111.445 -2.616 . . . . 0.0 114.027 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 49.3 t -69.61 134.2 48.49 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.047 0.927 . . . . 0.0 112.11 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.5 t -60.63 125.24 22.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 113.765 -1.562 . . . . 0.0 109.46 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.05 -18.68 9.45 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.667 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -21.84 62.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 17.9 m -82.11 -11.51 58.72 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.25 147.26 90.33 Favored Pre-proline 0 N--CA 1.428 -1.542 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.779 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 67.3 Cg_endo -93.44 10.57 53.69 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 120.097 1.07 . . . . 0.0 112.261 0.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.44 -38.15 80.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 88.7 m 57.66 38.84 27.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.113 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 115.79 34.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.992 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.5 Cg_exo -42.79 -32.76 2.68 Favored 'Trans proline' 0 CA--C 1.51 -0.715 0 C-N-CA 122.175 1.916 . . . . 0.0 113.174 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.874 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.89 -39.37 93.37 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.839 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.0 t -83.18 -32.7 26.45 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.4 m -65.67 -53.89 34.99 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.865 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.29 -15.23 12.86 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.874 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -159.13 114.8 2.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.111 1.456 . . . . 0.0 113.62 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.57 108.24 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.458 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -169.13 81.32 0.13 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.475 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.4 pp -76.34 -0.33 22.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.69 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 122.76 1.267 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.3 m -86.63 149.3 48.37 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.81 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.38 159.76 5.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.688 1.037 . . . . 0.0 113.437 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.54 119.57 6.31 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.115 -2.311 . . . . 0.0 109.167 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.95 1.76 58.43 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 111.43 -2.623 . . . . 0.0 114.105 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 53.8 t -69.61 133.75 47.95 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.016 0.912 . . . . 0.0 112.014 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.0 t -60.75 126.09 26.12 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.511 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.99 -17.91 10.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.596 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.0 -22.17 62.2 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.5 m -82.01 -12.12 58.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.31 147.55 90.36 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.418 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 97.7 Cg_endo -92.58 10.8 56.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 120.018 1.042 . . . . 0.0 112.111 -0.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -68.67 -37.97 80.01 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.6 m 57.99 39.71 26.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG3' ' HZ3' ' A' ' 21' ' ' LYS . 11.0 mttm -68.11 115.64 30.8 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 74.7 Cg_exo -43.33 -33.27 3.85 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 122.146 1.897 . . . . 0.0 113.272 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.86 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.52 -38.72 93.64 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.848 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.18 -33.29 26.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.9 m -65.43 -54.57 26.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.207 -1.36 . . . . 0.0 113.993 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.18 -16.31 12.61 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.86 ' O ' ' O ' ' A' ' 23' ' ' GLY . 6.9 pt20 -159.77 117.92 2.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.033 1.416 . . . . 0.0 114.526 -174.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.9 t -105.81 109.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.337 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -171.13 81.71 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.715 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -98.46 20.27 13.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.896 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.88 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 8' ' ' CYS . 8.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 122.765 1.269 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.804 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.76 149.19 47.78 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 112.192 -2.276 . . . . 0.0 106.901 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -53.0 159.6 5.11 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 CA-C-O 122.643 1.018 . . . . 0.0 113.502 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 p -56.67 119.66 6.52 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.205 -2.27 . . . . 0.0 109.165 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.75 1.86 58.65 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 111.346 -2.661 . . . . 0.0 114.112 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.9 t -69.56 133.72 47.97 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.067 0.937 . . . . 0.0 112.15 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -60.77 125.84 25.21 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.67 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.58 -18.51 10.74 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.737 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.99 -21.82 62.25 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 117.42 0.61 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.4 m -82.16 -11.77 58.53 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.32 146.31 89.14 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.157 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 68.3 Cg_endo -93.28 11.08 53.57 Favored 'Cis proline' 0 C--N 1.354 0.851 0 CA-C-N 120.098 1.071 . . . . 0.0 112.276 -0.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 5.9 mm-40 -68.33 -37.79 80.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 91.0 m 57.69 39.07 27.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.962 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -68.8 114.29 21.72 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.224 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 64.4 Cg_exo -41.92 -33.35 2.07 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.309 2.006 . . . . 0.0 113.259 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.829 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -67.02 -38.86 92.97 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.845 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.32 -33.33 25.94 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.5 m -65.6 -54.11 32.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 114.207 -1.361 . . . . 0.0 113.87 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.28 -16.28 12.53 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 116.436 1.335 . . . . 0.0 116.436 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.829 ' O ' ' O ' ' A' ' 23' ' ' GLY . 11.1 pt20 -159.26 114.87 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.111 1.456 . . . . 0.0 114.312 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -105.22 109.93 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.013 -1.448 . . . . 0.0 108.448 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -169.37 80.42 0.12 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.787 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.66 21.08 12.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.675 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.757 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 122.857 1.313 . . . . 0.0 112.431 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.5 149.22 48.55 Favored Pre-proline 0 N--CA 1.424 -1.739 0 CA-C-N 112.284 -2.234 . . . . 0.0 106.897 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -52.76 160.58 3.8 Favored 'Trans proline' 0 N--CA 1.432 -2.113 0 CA-C-O 122.629 1.012 . . . . 0.0 113.625 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -56.72 119.21 5.78 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.151 -2.295 . . . . 0.0 109.134 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.02 58.83 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.268 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.9 t -69.22 134.3 49.04 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 122.043 0.925 . . . . 0.0 111.947 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 t -60.8 125.77 24.92 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.677 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.27 -18.43 9.7 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.62 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.29 -22.24 61.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.067 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.27 -11.61 58.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.4 147.48 90.07 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.108 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 72.2 Cg_endo -92.78 10.24 56.64 Favored 'Cis proline' 0 C--N 1.354 0.82 0 CA-C-N 120.258 1.128 . . . . 0.0 112.072 -0.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.876 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 3.9 mm-40 -68.5 -38.45 80.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 95.5 m 57.86 38.94 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.876 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 10.7 mttm -68.04 114.51 21.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.1 Cg_exo -42.1 -32.51 1.94 Allowed 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 122.391 2.06 . . . . 0.0 113.08 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.83 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.75 -39.82 93.69 Favored Glycine 0 C--N 1.305 -1.159 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.723 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.94 -32.22 27.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.6 m -65.44 -54.44 28.49 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.941 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.26 -14.59 11.58 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.766 1.466 . . . . 0.0 116.766 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.83 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.7 pt20 -159.69 117.18 2.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.36 1.58 . . . . 0.0 113.951 -175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 t -94.9 106.62 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -112.99 53.39 0.75 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.708 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -97.32 18.61 14.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.182 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.209 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.7 t . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 122.724 1.25 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.808 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.56 149.35 48.67 Favored Pre-proline 0 N--CA 1.423 -1.79 0 CA-C-N 112.306 -2.225 . . . . 0.0 106.694 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.35 160.16 5.19 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-O 122.674 1.031 . . . . 0.0 113.513 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -56.51 119.65 6.43 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.101 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.79 58.88 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.213 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t -69.57 133.88 48.14 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 118.007 0.903 . . . . 0.0 111.973 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -60.78 126.25 26.72 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.617 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.94 -17.76 10.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.646 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -71.21 -22.29 62.03 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 117.44 0.62 . . . . 0.0 111.009 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.7 m -81.97 -11.65 58.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.27 147.8 90.64 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.553 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 56.0 Cg_endo -92.89 10.24 56.38 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.044 1.051 . . . . 0.0 112.096 -0.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.52 -37.5 80.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.7 m 57.92 40.13 26.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 21' ' ' LYS . 1.6 mtmp? -67.89 114.6 21.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.9 -32.92 2.85 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.271 1.981 . . . . 0.0 113.192 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.973 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.53 -39.21 93.9 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.737 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.3 t -83.03 -33.0 26.59 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.808 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.5 m -65.13 -54.18 33.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.711 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.74 -16.92 10.94 Favored Glycine 0 C--N 1.31 -0.912 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.973 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -160.65 123.02 3.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 114.026 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.4 106.49 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.447 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -113.54 71.18 0.74 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.095 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.83 18.01 12.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.847 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.792 179.755 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.1 t . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 122.868 1.318 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.808 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.6 m -86.68 149.46 48.6 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-N 112.288 -2.233 . . . . 0.0 106.978 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.3 Cg_exo -52.94 159.24 5.41 Favored 'Trans proline' 0 N--CA 1.43 -2.234 0 CA-C-O 122.702 1.043 . . . . 0.0 113.392 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.31 120.32 7.43 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.069 -173.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.29 1.78 59.24 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 111.274 -2.694 . . . . 0.0 114.304 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.5 t -69.45 133.75 48.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.094 0.949 . . . . 0.0 112.075 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -61.03 126.31 26.88 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.581 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.67 -17.98 9.98 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.583 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -70.92 -22.54 62.23 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.04 -11.62 58.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.6 t80 -72.47 147.69 90.03 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.635 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 46.0 Cg_endo -92.99 10.29 56.03 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.147 1.088 . . . . 0.0 112.02 -0.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.23 -38.29 81.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 89.7 m 57.97 39.6 26.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -67.71 114.93 22.58 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.79 -32.85 2.71 Favored 'Trans proline' 0 CA--C 1.511 -0.666 0 C-N-CA 122.286 1.991 . . . . 0.0 112.97 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.797 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.03 -39.61 94.84 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.014 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -83.08 -32.25 26.89 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.808 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.34 -54.28 31.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.69 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.06 -14.27 10.15 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 116.987 1.555 . . . . 0.0 116.987 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.797 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -159.88 118.89 2.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.537 1.668 . . . . 0.0 114.519 -174.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 t -97.57 105.56 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -109.11 56.46 0.62 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.262 0.553 . . . . 0.0 109.926 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.99 13.94 13.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.965 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.892 -179.69 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' CYS . 12.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 122.811 1.291 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.4 m -86.52 149.36 48.79 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 112.227 -2.26 . . . . 0.0 106.888 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.1 160.12 4.76 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 CA-C-O 122.631 1.013 . . . . 0.0 113.521 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 p -56.58 119.77 6.65 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.127 -2.306 . . . . 0.0 109.104 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.25 1.97 59.23 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 111.467 -2.606 . . . . 0.0 114.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 52.0 t -69.42 133.82 48.23 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.035 0.917 . . . . 0.0 112.071 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -60.9 125.8 25.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.574 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.65 -18.46 10.85 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.725 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.09 -21.77 62.18 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.034 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.2 -11.46 58.68 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.37 147.14 89.91 Favored Pre-proline 0 N--CA 1.428 -1.532 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.062 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 85.0 Cg_endo -92.91 10.89 55.29 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.188 1.103 . . . . 0.0 112.278 -0.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -68.31 -38.69 81.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 84.3 m 57.58 38.66 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.672 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 113.78 17.87 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 56.8 Cg_exo -41.4 -32.85 1.39 Allowed 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 122.229 1.953 . . . . 0.0 113.18 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.861 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.61 -39.36 93.81 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.868 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.42 -32.72 25.95 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.37 -53.99 35.33 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.871 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.71 -15.55 10.94 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.861 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.9 pt20 -159.95 118.47 2.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.254 1.527 . . . . 0.0 113.73 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 N--CA 1.443 -0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.577 178.168 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 8' ' ' CYS . 11.4 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 122.773 1.273 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.811 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.23 149.23 49.29 Favored Pre-proline 0 N--CA 1.425 -1.697 0 CA-C-N 112.299 -2.228 . . . . 0.0 106.517 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.75 160.93 4.99 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 CA-C-O 122.778 1.074 . . . . 0.0 113.575 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 p -56.64 119.2 5.74 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.98 -2.373 . . . . 0.0 109.228 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.13 59.3 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 111.496 -2.593 . . . . 0.0 114.138 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 50.7 t -69.21 134.28 49.03 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.069 0.938 . . . . 0.0 111.868 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -60.84 125.09 22.41 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.39 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -53.9 -18.37 8.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.516 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -22.01 62.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 117.199 0.499 . . . . 0.0 111.332 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 19.5 m -82.22 -11.25 58.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.561 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.49 147.21 89.65 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.362 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 96.6 Cg_endo -92.64 11.09 55.54 Favored 'Cis proline' 0 C--N 1.352 0.716 0 CA-C-N 120.13 1.082 . . . . 0.0 112.145 -0.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 23.2 mt-10 -68.17 -38.7 82.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 92.8 m 57.67 38.31 27.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.876 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -68.6 114.76 24.26 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 60.2 Cg_exo -42.54 -31.95 2.12 Favored 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.19 1.927 . . . . 0.0 113.058 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.51 -39.87 94.12 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.905 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.9 t -83.55 -32.34 25.91 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.811 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.0 m -65.47 -53.31 44.52 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.0 -1.455 . . . . 0.0 113.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.42 -15.36 8.95 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.705 ' O ' ' O ' ' A' ' 23' ' ' GLY . 7.3 pt20 -160.84 119.21 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.638 1.719 . . . . 0.0 115.159 -174.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 CA--C 1.519 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.753 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 8' ' ' CYS . 7.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 122.817 1.294 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.804 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.77 149.29 47.98 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 112.223 -2.262 . . . . 0.0 106.906 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.38 160.42 4.94 Favored 'Trans proline' 0 N--CA 1.431 -2.179 0 CA-C-O 122.725 1.052 . . . . 0.0 113.506 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -56.57 119.76 6.64 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.156 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.49 1.77 58.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 111.495 -2.593 . . . . 0.0 114.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 52.9 t -69.69 133.78 47.92 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.056 0.931 . . . . 0.0 112.201 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -60.82 126.48 27.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.621 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.97 -17.85 10.49 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.649 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.2 -22.48 62.01 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 15.1 m -81.97 -11.53 58.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.24 147.4 90.47 Favored Pre-proline 0 N--CA 1.432 -1.366 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.3 Cg_endo -92.38 11.03 56.26 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.115 1.077 . . . . 0.0 111.868 -0.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.95 -38.97 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 85.7 m 57.91 38.55 27.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.697 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -68.11 114.82 23.2 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 73.5 Cg_exo -43.04 -32.35 2.76 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.242 1.961 . . . . 0.0 113.151 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.914 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.77 -39.81 93.66 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.157 -1.02 . . . . 0.0 111.677 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 t -82.99 -32.73 26.82 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -65.29 -54.14 33.52 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.783 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.45 -16.04 10.69 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.914 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 pt20 -160.93 123.96 3.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.373 1.586 . . . . 0.0 114.727 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.447 -0.602 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.055 177.552 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 8' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 122.775 1.274 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.823 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.69 148.61 46.56 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.246 -2.252 . . . . 0.0 106.7 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.22 159.78 5.37 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-O 122.569 0.987 . . . . 0.0 113.513 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.59 120.0 7.04 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.187 -2.279 . . . . 0.0 109.061 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.23 1.87 59.28 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 111.362 -2.654 . . . . 0.0 113.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.8 t -69.44 133.93 48.33 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.944 0.878 . . . . 0.0 111.69 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -60.64 125.55 24.11 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.55 -18.29 10.24 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.588 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -71.09 -21.92 62.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.19 -11.72 58.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.601 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.43 147.87 90.26 Favored Pre-proline 0 N--CA 1.431 -1.419 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.372 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 98.0 Cg_endo -93.16 10.57 54.91 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 120.072 1.061 . . . . 0.0 112.04 -0.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.855 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 2.3 mm-40 -68.83 -37.91 79.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 99.1 m 57.92 40.22 25.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.855 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 8.1 mttm -68.01 115.47 28.78 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 72.6 Cg_exo -43.07 -33.17 3.22 Favored 'Trans proline' 0 CA--C 1.51 -0.679 0 C-N-CA 122.198 1.932 . . . . 0.0 113.021 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.834 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.31 -38.97 94.15 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.875 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.4 t -83.02 -32.99 26.61 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.823 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.3 m -65.32 -54.19 32.6 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.858 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.18 -14.7 11.49 Favored Glycine 0 C--N 1.308 -0.974 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.834 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -159.51 118.51 2.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.416 1.608 . . . . 0.0 114.602 -174.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.25 178.047 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' CYS . 7.4 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.824 1.297 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.46 148.65 47.27 Favored Pre-proline 0 N--CA 1.424 -1.733 0 CA-C-N 112.21 -2.268 . . . . 0.0 106.93 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 Cg_exo -52.75 159.21 5.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.57 0.987 . . . . 0.0 113.484 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 p -56.4 119.63 6.35 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 112.232 -2.258 . . . . 0.0 109.07 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.03 58.9 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 111.445 -2.616 . . . . 0.0 114.027 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 49.3 t -69.61 134.2 48.49 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.047 0.927 . . . . 0.0 112.11 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.5 t -60.63 125.24 22.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 113.765 -1.562 . . . . 0.0 109.46 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.05 -18.68 9.45 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.667 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -21.84 62.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 17.9 m -82.11 -11.51 58.72 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.25 147.26 90.33 Favored Pre-proline 0 N--CA 1.428 -1.542 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.779 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 67.3 Cg_endo -93.44 10.57 53.69 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 120.097 1.07 . . . . 0.0 112.261 0.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.44 -38.15 80.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 88.7 m 57.66 38.84 27.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.113 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 115.79 34.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.992 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.5 Cg_exo -42.79 -32.76 2.68 Favored 'Trans proline' 0 CA--C 1.51 -0.715 0 C-N-CA 122.175 1.916 . . . . 0.0 113.174 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.874 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.89 -39.37 93.37 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.839 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.0 t -83.18 -32.7 26.45 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.4 m -65.67 -53.89 34.99 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.865 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.29 -15.23 12.86 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.874 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -159.13 114.8 2.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.111 1.456 . . . . 0.0 113.62 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.458 178.181 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 122.76 1.267 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.3 m -86.63 149.3 48.37 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.81 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.38 159.76 5.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.688 1.037 . . . . 0.0 113.437 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.54 119.57 6.31 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.115 -2.311 . . . . 0.0 109.167 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.95 1.76 58.43 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 111.43 -2.623 . . . . 0.0 114.105 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 53.8 t -69.61 133.75 47.95 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.016 0.912 . . . . 0.0 112.014 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.0 t -60.75 126.09 26.12 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.511 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.99 -17.91 10.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.596 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.0 -22.17 62.2 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.5 m -82.01 -12.12 58.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.31 147.55 90.36 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.418 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 97.7 Cg_endo -92.58 10.8 56.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 120.018 1.042 . . . . 0.0 112.111 -0.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -68.67 -37.97 80.01 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.6 m 57.99 39.71 26.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG3' ' HZ3' ' A' ' 21' ' ' LYS . 11.0 mttm -68.11 115.64 30.8 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 74.7 Cg_exo -43.33 -33.27 3.85 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 122.146 1.897 . . . . 0.0 113.272 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.86 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.52 -38.72 93.64 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.848 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.18 -33.29 26.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.9 m -65.43 -54.57 26.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.207 -1.36 . . . . 0.0 113.993 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.18 -16.31 12.61 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.86 ' O ' ' O ' ' A' ' 23' ' ' GLY . 6.9 pt20 -159.77 117.92 2.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.033 1.416 . . . . 0.0 114.526 -174.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.9 t . . . . . 0 N--CA 1.445 -0.698 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.337 177.825 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 8' ' ' CYS . 8.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 122.765 1.269 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.804 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.76 149.19 47.78 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 112.192 -2.276 . . . . 0.0 106.901 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -53.0 159.6 5.11 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 CA-C-O 122.643 1.018 . . . . 0.0 113.502 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 p -56.67 119.66 6.52 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.205 -2.27 . . . . 0.0 109.165 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.75 1.86 58.65 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 111.346 -2.661 . . . . 0.0 114.112 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.9 t -69.56 133.72 47.97 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.067 0.937 . . . . 0.0 112.15 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -60.77 125.84 25.21 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.67 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.58 -18.51 10.74 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.737 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.99 -21.82 62.25 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 117.42 0.61 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.4 m -82.16 -11.77 58.53 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.32 146.31 89.14 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.157 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 68.3 Cg_endo -93.28 11.08 53.57 Favored 'Cis proline' 0 C--N 1.354 0.851 0 CA-C-N 120.098 1.071 . . . . 0.0 112.276 -0.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 5.9 mm-40 -68.33 -37.79 80.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 91.0 m 57.69 39.07 27.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.962 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -68.8 114.29 21.72 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.224 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 64.4 Cg_exo -41.92 -33.35 2.07 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.309 2.006 . . . . 0.0 113.259 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.829 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -67.02 -38.86 92.97 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.845 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.32 -33.33 25.94 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.5 m -65.6 -54.11 32.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 114.207 -1.361 . . . . 0.0 113.87 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.28 -16.28 12.53 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 116.436 1.335 . . . . 0.0 116.436 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.829 ' O ' ' O ' ' A' ' 23' ' ' GLY . 11.1 pt20 -159.26 114.87 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.111 1.456 . . . . 0.0 114.312 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 114.013 -1.448 . . . . 0.0 108.448 177.809 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 122.857 1.313 . . . . 0.0 112.431 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.5 149.22 48.55 Favored Pre-proline 0 N--CA 1.424 -1.739 0 CA-C-N 112.284 -2.234 . . . . 0.0 106.897 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -52.76 160.58 3.8 Favored 'Trans proline' 0 N--CA 1.432 -2.113 0 CA-C-O 122.629 1.012 . . . . 0.0 113.625 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -56.72 119.21 5.78 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.151 -2.295 . . . . 0.0 109.134 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.02 58.83 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.268 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.9 t -69.22 134.3 49.04 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 122.043 0.925 . . . . 0.0 111.947 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 t -60.8 125.77 24.92 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.677 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.27 -18.43 9.7 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.62 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.29 -22.24 61.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.067 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.27 -11.61 58.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.4 147.48 90.07 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.108 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 72.2 Cg_endo -92.78 10.24 56.64 Favored 'Cis proline' 0 C--N 1.354 0.82 0 CA-C-N 120.258 1.128 . . . . 0.0 112.072 -0.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.876 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 3.9 mm-40 -68.5 -38.45 80.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 95.5 m 57.86 38.94 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.876 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 10.7 mttm -68.04 114.51 21.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.1 Cg_exo -42.1 -32.51 1.94 Allowed 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 122.391 2.06 . . . . 0.0 113.08 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.83 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.75 -39.82 93.69 Favored Glycine 0 C--N 1.305 -1.159 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.723 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.94 -32.22 27.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.6 m -65.44 -54.44 28.49 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.941 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.26 -14.59 11.58 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.766 1.466 . . . . 0.0 116.766 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.83 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.1 pt20 -159.69 117.18 2.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.36 1.58 . . . . 0.0 113.951 -175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.724 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.7 t . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 122.724 1.25 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.808 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.56 149.35 48.67 Favored Pre-proline 0 N--CA 1.423 -1.79 0 CA-C-N 112.306 -2.225 . . . . 0.0 106.694 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.35 160.16 5.19 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-O 122.674 1.031 . . . . 0.0 113.513 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -56.51 119.65 6.43 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.101 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.79 58.88 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.213 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t -69.57 133.88 48.14 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 118.007 0.903 . . . . 0.0 111.973 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -60.78 126.25 26.72 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.617 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.94 -17.76 10.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.646 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -71.21 -22.29 62.03 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 117.44 0.62 . . . . 0.0 111.009 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.7 m -81.97 -11.65 58.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.27 147.8 90.64 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.553 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 56.0 Cg_endo -92.89 10.24 56.38 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.044 1.051 . . . . 0.0 112.096 -0.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.52 -37.5 80.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.7 m 57.92 40.13 26.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 21' ' ' LYS . 1.6 mtmp? -67.89 114.6 21.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.9 -32.92 2.85 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.271 1.981 . . . . 0.0 113.192 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.973 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.53 -39.21 93.9 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.737 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.3 t -83.03 -33.0 26.59 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.808 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.5 m -65.13 -54.18 33.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.711 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.74 -16.92 10.94 Favored Glycine 0 C--N 1.31 -0.912 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.973 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -160.65 123.02 3.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 114.026 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.447 178.104 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.1 t . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 122.868 1.318 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.808 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.6 m -86.68 149.46 48.6 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-N 112.288 -2.233 . . . . 0.0 106.978 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.3 Cg_exo -52.94 159.24 5.41 Favored 'Trans proline' 0 N--CA 1.43 -2.234 0 CA-C-O 122.702 1.043 . . . . 0.0 113.392 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.31 120.32 7.43 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.069 -173.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.29 1.78 59.24 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 111.274 -2.694 . . . . 0.0 114.304 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.5 t -69.45 133.75 48.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.094 0.949 . . . . 0.0 112.075 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -61.03 126.31 26.88 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.581 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.67 -17.98 9.98 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.583 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -70.92 -22.54 62.23 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.04 -11.62 58.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.6 t80 -72.47 147.69 90.03 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.635 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 46.0 Cg_endo -92.99 10.29 56.03 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.147 1.088 . . . . 0.0 112.02 -0.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.23 -38.29 81.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 89.7 m 57.97 39.6 26.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -67.71 114.93 22.58 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.79 -32.85 2.71 Favored 'Trans proline' 0 CA--C 1.511 -0.666 0 C-N-CA 122.286 1.991 . . . . 0.0 112.97 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.797 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.03 -39.61 94.84 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.014 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -83.08 -32.25 26.89 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.808 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.34 -54.28 31.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.69 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.06 -14.27 10.15 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 116.987 1.555 . . . . 0.0 116.987 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.797 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -159.88 118.89 2.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.537 1.668 . . . . 0.0 114.519 -174.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.443 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' CYS . 12.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 122.811 1.291 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.4 m -86.52 149.36 48.79 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 112.227 -2.26 . . . . 0.0 106.888 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.1 160.12 4.76 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 CA-C-O 122.631 1.013 . . . . 0.0 113.521 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 p -56.58 119.77 6.65 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.127 -2.306 . . . . 0.0 109.104 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.25 1.97 59.23 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 111.467 -2.606 . . . . 0.0 114.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 52.0 t -69.42 133.82 48.23 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.035 0.917 . . . . 0.0 112.071 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -60.9 125.8 25.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.574 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.65 -18.46 10.85 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.725 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.09 -21.77 62.18 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.034 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.2 -11.46 58.68 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.37 147.14 89.91 Favored Pre-proline 0 N--CA 1.428 -1.532 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.062 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 85.0 Cg_endo -92.91 10.89 55.29 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.188 1.103 . . . . 0.0 112.278 -0.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -68.31 -38.69 81.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 84.3 m 57.58 38.66 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.672 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 113.78 17.87 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 56.8 Cg_exo -41.4 -32.85 1.39 Allowed 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 122.229 1.953 . . . . 0.0 113.18 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.861 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.61 -39.36 93.81 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.868 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.42 -32.72 25.95 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.37 -53.99 35.33 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.871 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.71 -15.55 10.94 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.861 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.9 pt20 -159.95 118.47 2.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.254 1.527 . . . . 0.0 113.73 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.13 106.58 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.577 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.99 82.4 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.14 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 mt -107.18 25.72 11.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.779 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.729 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 8' ' ' CYS . 11.4 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 122.773 1.273 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.811 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.23 149.23 49.29 Favored Pre-proline 0 N--CA 1.425 -1.697 0 CA-C-N 112.299 -2.228 . . . . 0.0 106.517 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.75 160.93 4.99 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 CA-C-O 122.778 1.074 . . . . 0.0 113.575 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 p -56.64 119.2 5.74 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.98 -2.373 . . . . 0.0 109.228 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.13 59.3 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 111.496 -2.593 . . . . 0.0 114.138 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 50.7 t -69.21 134.28 49.03 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.069 0.938 . . . . 0.0 111.868 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -60.84 125.09 22.41 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.39 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -53.9 -18.37 8.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.516 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -22.01 62.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 117.199 0.499 . . . . 0.0 111.332 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 19.5 m -82.22 -11.25 58.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.561 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.49 147.21 89.65 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.362 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 96.6 Cg_endo -92.64 11.09 55.54 Favored 'Cis proline' 0 C--N 1.352 0.716 0 CA-C-N 120.13 1.082 . . . . 0.0 112.145 -0.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 23.2 mt-10 -68.17 -38.7 82.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 92.8 m 57.67 38.31 27.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.876 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -68.6 114.76 24.26 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 60.2 Cg_exo -42.54 -31.95 2.12 Favored 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.19 1.927 . . . . 0.0 113.058 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.51 -39.87 94.12 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.905 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.9 t -83.55 -32.34 25.91 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.811 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.0 m -65.47 -53.31 44.52 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.0 -1.455 . . . . 0.0 113.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.42 -15.36 8.95 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.705 ' O ' ' O ' ' A' ' 23' ' ' GLY . 7.3 pt20 -160.84 119.21 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.638 1.719 . . . . 0.0 115.159 -174.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -96.95 105.5 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.25 52.57 0.72 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.1 20.24 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.962 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 8' ' ' CYS . 7.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 122.817 1.294 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.804 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.77 149.29 47.98 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 112.223 -2.262 . . . . 0.0 106.906 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.38 160.42 4.94 Favored 'Trans proline' 0 N--CA 1.431 -2.179 0 CA-C-O 122.725 1.052 . . . . 0.0 113.506 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -56.57 119.76 6.64 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.156 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.49 1.77 58.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 111.495 -2.593 . . . . 0.0 114.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 52.9 t -69.69 133.78 47.92 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.056 0.931 . . . . 0.0 112.201 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -60.82 126.48 27.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.621 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.97 -17.85 10.49 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.649 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.2 -22.48 62.01 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 15.1 m -81.97 -11.53 58.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.24 147.4 90.47 Favored Pre-proline 0 N--CA 1.432 -1.366 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.3 Cg_endo -92.38 11.03 56.26 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.115 1.077 . . . . 0.0 111.868 -0.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.95 -38.97 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 85.7 m 57.91 38.55 27.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.697 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -68.11 114.82 23.2 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 73.5 Cg_exo -43.04 -32.35 2.76 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.242 1.961 . . . . 0.0 113.151 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.914 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.77 -39.81 93.66 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.157 -1.02 . . . . 0.0 111.677 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 t -82.99 -32.73 26.82 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -65.29 -54.14 33.52 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.783 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.45 -16.04 10.69 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.914 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 pt20 -160.93 123.96 3.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.373 1.586 . . . . 0.0 114.727 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 t -100.72 106.69 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.055 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.73 78.88 1.16 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.116 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.11 18.81 10.12 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.719 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.914 179.76 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 8' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 122.775 1.274 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.823 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.69 148.61 46.56 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.246 -2.252 . . . . 0.0 106.7 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.7 Cg_exo -53.22 159.78 5.37 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-O 122.569 0.987 . . . . 0.0 113.513 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.59 120.0 7.04 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.187 -2.279 . . . . 0.0 109.061 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.23 1.87 59.28 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 111.362 -2.654 . . . . 0.0 113.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.8 t -69.44 133.93 48.33 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.944 0.878 . . . . 0.0 111.69 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -60.64 125.55 24.11 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.55 -18.29 10.24 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.588 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -71.09 -21.92 62.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.19 -11.72 58.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.601 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.43 147.87 90.26 Favored Pre-proline 0 N--CA 1.431 -1.419 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.372 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 98.0 Cg_endo -93.16 10.57 54.91 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 120.072 1.061 . . . . 0.0 112.04 -0.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.855 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 2.3 mm-40 -68.83 -37.91 79.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 99.1 m 57.92 40.22 25.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.855 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 8.1 mttm -68.01 115.47 28.78 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 72.6 Cg_exo -43.07 -33.17 3.22 Favored 'Trans proline' 0 CA--C 1.51 -0.679 0 C-N-CA 122.198 1.932 . . . . 0.0 113.021 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.834 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.31 -38.97 94.15 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.875 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.4 t -83.02 -32.99 26.61 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.823 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.3 m -65.32 -54.19 32.6 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.858 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.18 -14.7 11.49 Favored Glycine 0 C--N 1.308 -0.974 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.834 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -159.51 118.51 2.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.416 1.608 . . . . 0.0 114.602 -174.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.92 107.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.25 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.491 HD22 ' H ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -174.92 83.1 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.977 177.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 tp -94.69 17.77 12.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.347 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.491 ' H ' HD22 ' A' ' 29' ' ' ASN . 2.0 m120 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.656 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' CYS . 7.4 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.824 1.297 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 8.9 m -86.46 148.65 47.27 Favored Pre-proline 0 N--CA 1.424 -1.733 0 CA-C-N 112.21 -2.268 . . . . 0.0 106.93 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 Cg_exo -52.75 159.21 5.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.57 0.987 . . . . 0.0 113.484 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 p -56.4 119.63 6.35 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 112.232 -2.258 . . . . 0.0 109.07 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.03 58.9 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 111.445 -2.616 . . . . 0.0 114.027 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 49.3 t -69.61 134.2 48.49 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.047 0.927 . . . . 0.0 112.11 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.5 t -60.63 125.24 22.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 113.765 -1.562 . . . . 0.0 109.46 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.05 -18.68 9.45 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.667 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.08 -21.84 62.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 17.9 m -82.11 -11.51 58.72 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.3 t80 -72.25 147.26 90.33 Favored Pre-proline 0 N--CA 1.428 -1.542 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.779 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 67.3 Cg_endo -93.44 10.57 53.69 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 120.097 1.07 . . . . 0.0 112.261 0.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.44 -38.15 80.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 88.7 m 57.66 38.84 27.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.113 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 115.79 34.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.992 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.5 Cg_exo -42.79 -32.76 2.68 Favored 'Trans proline' 0 CA--C 1.51 -0.715 0 C-N-CA 122.175 1.916 . . . . 0.0 113.174 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.874 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.89 -39.37 93.37 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.839 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.0 t -83.18 -32.7 26.45 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.4 m -65.67 -53.89 34.99 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.865 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.29 -15.23 12.86 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.874 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -159.13 114.8 2.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.111 1.456 . . . . 0.0 113.62 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.57 108.24 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.458 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -169.13 81.32 0.13 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.475 177.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.4 pp -76.34 -0.33 22.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.69 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 122.76 1.267 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.3 m -86.63 149.3 48.37 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.81 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.38 159.76 5.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 CA-C-O 122.688 1.037 . . . . 0.0 113.437 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -56.54 119.57 6.31 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 112.115 -2.311 . . . . 0.0 109.167 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.95 1.76 58.43 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 111.43 -2.623 . . . . 0.0 114.105 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 53.8 t -69.61 133.75 47.95 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.016 0.912 . . . . 0.0 112.014 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.0 t -60.75 126.09 26.12 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.511 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.99 -17.91 10.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.596 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.0 -22.17 62.2 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.5 m -82.01 -12.12 58.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.7 t80 -72.31 147.55 90.36 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.418 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 97.7 Cg_endo -92.58 10.8 56.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 120.018 1.042 . . . . 0.0 112.111 -0.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -68.67 -37.97 80.01 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.6 m 57.99 39.71 26.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG3' ' HZ3' ' A' ' 21' ' ' LYS . 11.0 mttm -68.11 115.64 30.8 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 74.7 Cg_exo -43.33 -33.27 3.85 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 122.146 1.897 . . . . 0.0 113.272 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.86 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.52 -38.72 93.64 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.848 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.18 -33.29 26.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.9 m -65.43 -54.57 26.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.207 -1.36 . . . . 0.0 113.993 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.18 -16.31 12.61 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.86 ' O ' ' O ' ' A' ' 23' ' ' GLY . 6.9 pt20 -159.77 117.92 2.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.033 1.416 . . . . 0.0 114.526 -174.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.9 t -105.81 109.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.337 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.13 81.71 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.715 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -98.46 20.27 13.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.896 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.88 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 8' ' ' CYS . 8.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 122.765 1.269 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.804 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.76 149.19 47.78 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 112.192 -2.276 . . . . 0.0 106.901 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -53.0 159.6 5.11 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 CA-C-O 122.643 1.018 . . . . 0.0 113.502 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 p -56.67 119.66 6.52 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.205 -2.27 . . . . 0.0 109.165 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.75 1.86 58.65 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 111.346 -2.661 . . . . 0.0 114.112 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.9 t -69.56 133.72 47.97 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.067 0.937 . . . . 0.0 112.15 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -60.77 125.84 25.21 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.67 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.58 -18.51 10.74 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.737 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.99 -21.82 62.25 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 117.42 0.61 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.4 m -82.16 -11.77 58.53 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.32 146.31 89.14 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.157 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 68.3 Cg_endo -93.28 11.08 53.57 Favored 'Cis proline' 0 C--N 1.354 0.851 0 CA-C-N 120.098 1.071 . . . . 0.0 112.276 -0.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' HD2' ' A' ' 21' ' ' LYS . 5.9 mm-40 -68.33 -37.79 80.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 91.0 m 57.69 39.07 27.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.962 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HD2' ' CB ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -68.8 114.29 21.72 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.224 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 64.4 Cg_exo -41.92 -33.35 2.07 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.309 2.006 . . . . 0.0 113.259 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.829 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -67.02 -38.86 92.97 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.845 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.32 -33.33 25.94 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 54.5 m -65.6 -54.11 32.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 114.207 -1.361 . . . . 0.0 113.87 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.28 -16.28 12.53 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 116.436 1.335 . . . . 0.0 116.436 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.829 ' O ' ' O ' ' A' ' 23' ' ' GLY . 11.1 pt20 -159.26 114.87 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.111 1.456 . . . . 0.0 114.312 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -105.22 109.93 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.013 -1.448 . . . . 0.0 108.448 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.37 80.42 0.12 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.787 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.66 21.08 12.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.675 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.757 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 122.857 1.313 . . . . 0.0 112.431 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.1 m -86.5 149.22 48.55 Favored Pre-proline 0 N--CA 1.424 -1.739 0 CA-C-N 112.284 -2.234 . . . . 0.0 106.897 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.1 Cg_exo -52.76 160.58 3.8 Favored 'Trans proline' 0 N--CA 1.432 -2.113 0 CA-C-O 122.629 1.012 . . . . 0.0 113.625 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -56.72 119.21 5.78 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.151 -2.295 . . . . 0.0 109.134 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.02 58.83 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.268 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.9 t -69.22 134.3 49.04 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 122.043 0.925 . . . . 0.0 111.947 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 t -60.8 125.77 24.92 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.677 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.27 -18.43 9.7 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.62 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.29 -22.24 61.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.067 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 16.2 m -82.27 -11.61 58.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.5 t80 -72.4 147.48 90.07 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.108 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 72.2 Cg_endo -92.78 10.24 56.64 Favored 'Cis proline' 0 C--N 1.354 0.82 0 CA-C-N 120.258 1.128 . . . . 0.0 112.072 -0.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.876 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 3.9 mm-40 -68.5 -38.45 80.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 95.5 m 57.86 38.94 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.876 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 10.7 mttm -68.04 114.51 21.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 66.1 Cg_exo -42.1 -32.51 1.94 Allowed 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 122.391 2.06 . . . . 0.0 113.08 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.83 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.75 -39.82 93.69 Favored Glycine 0 C--N 1.305 -1.159 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.723 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.94 -32.22 27.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 52.6 m -65.44 -54.44 28.49 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.941 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.26 -14.59 11.58 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.766 1.466 . . . . 0.0 116.766 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.83 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.1 pt20 -159.69 117.18 2.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.36 1.58 . . . . 0.0 113.951 -175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 t -94.9 106.62 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.99 53.39 0.75 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.708 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -97.32 18.61 14.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.182 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.209 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.7 t . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 122.724 1.25 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.808 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.5 m -86.56 149.35 48.67 Favored Pre-proline 0 N--CA 1.423 -1.79 0 CA-C-N 112.306 -2.225 . . . . 0.0 106.694 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.35 160.16 5.19 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-O 122.674 1.031 . . . . 0.0 113.513 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -56.51 119.65 6.43 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.101 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.79 58.88 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.213 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t -69.57 133.88 48.14 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 118.007 0.903 . . . . 0.0 111.973 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -60.78 126.25 26.72 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.617 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.94 -17.76 10.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.646 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -71.21 -22.29 62.03 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 117.44 0.62 . . . . 0.0 111.009 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 11.7 m -81.97 -11.65 58.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.9 t80 -72.27 147.8 90.64 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.553 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 56.0 Cg_endo -92.89 10.24 56.38 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.044 1.051 . . . . 0.0 112.096 -0.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.52 -37.5 80.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 90.7 m 57.92 40.13 26.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 21' ' ' LYS . 1.6 mtmp? -67.89 114.6 21.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.9 -32.92 2.85 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.271 1.981 . . . . 0.0 113.192 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.973 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.53 -39.21 93.9 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.737 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.3 t -83.03 -33.0 26.59 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.808 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.5 m -65.13 -54.18 33.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.711 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.74 -16.92 10.94 Favored Glycine 0 C--N 1.31 -0.912 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.973 ' O ' ' O ' ' A' ' 23' ' ' GLY . 3.2 pt20 -160.65 123.02 3.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 114.026 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.4 106.49 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.447 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.54 71.18 0.74 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.095 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.83 18.01 12.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.847 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.792 179.755 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' CYS . 10.1 t . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 122.868 1.318 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.808 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.6 m -86.68 149.46 48.6 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-N 112.288 -2.233 . . . . 0.0 106.978 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.3 Cg_exo -52.94 159.24 5.41 Favored 'Trans proline' 0 N--CA 1.43 -2.234 0 CA-C-O 122.702 1.043 . . . . 0.0 113.392 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.31 120.32 7.43 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.069 -173.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.29 1.78 59.24 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 111.274 -2.694 . . . . 0.0 114.304 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 51.5 t -69.45 133.75 48.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.094 0.949 . . . . 0.0 112.075 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -61.03 126.31 26.88 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.581 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -54.67 -17.98 9.98 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.583 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -70.92 -22.54 62.23 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 14.8 m -82.04 -11.62 58.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HA ' ' A' ' 18' ' ' PRO . 3.6 t80 -72.47 147.69 90.03 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.635 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 46.0 Cg_endo -92.99 10.29 56.03 Favored 'Cis proline' 0 C--N 1.354 0.859 0 CA-C-N 120.147 1.088 . . . . 0.0 112.02 -0.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.23 -38.29 81.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 89.7 m 57.97 39.6 26.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -67.71 114.93 22.58 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 Cg_exo -42.79 -32.85 2.71 Favored 'Trans proline' 0 CA--C 1.511 -0.666 0 C-N-CA 122.286 1.991 . . . . 0.0 112.97 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.797 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -66.03 -39.61 94.84 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.014 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.1 t -83.08 -32.25 26.89 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.808 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.7 m -65.34 -54.28 31.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.69 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.06 -14.27 10.15 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 116.987 1.555 . . . . 0.0 116.987 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.797 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -159.88 118.89 2.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.537 1.668 . . . . 0.0 114.519 -174.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 t -97.57 105.56 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.11 56.46 0.62 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.262 0.553 . . . . 0.0 109.926 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.99 13.94 13.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.965 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.892 -179.69 . . . . . . . . 0 0 . 1 stop_ save_